Vaxcyte Inc
(PCVX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -100,077 | -71,514 | -44,899 | -21,220 | -89,217 |
| Depreciation Amortization | 4,863 | 3,161 | 1,876 | 678 | 1,405 |
| Accounts payable and accrued liabilities | -12,470 | 5,601 | 4,103 | 2,185 | 26,102 |
| Other Working Capital | -37,005 | -9,550 | -3,496 | 5,472 | 35,270 |
| Other Operating Activity | 23,296 | 2,002 | 531 | -320 | -20,188 |
| Operating Cash Flow | $-121,393 | $-70,300 | $-41,885 | $-13,205 | $-46,628 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -336,341 | -295,279 | -228,531 | -172,145 | N/A |
| PPE Investments | -6,529 | -5,173 | -3,454 | -1,246 | -1,105 |
| Sale Of Investment | 130,562 | 88,062 | 38,064 | N/A | N/A |
| Investing Cash Flow | $-212,308 | $-212,390 | $-193,921 | $-173,391 | $-1,105 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 264,007 |
| Debt Repayment | N/A | N/A | N/A | N/A | -61 |
| Common Stock Issued | 3,900 | 9,042 | 1,443 | 487 | 1,045 |
| Other Financing Activity | 13,896 | 0 | 0 | 0 | 109,879 |
| Financing Cash Flow | $17,796 | $9,042 | $1,443 | $487 | $374,870 |
| Exchange Rate Effect | -439 | 363 | 30 | -281 | 87 |
| Beginning Cash Position | 386,200 | 386,200 | 386,200 | 386,200 | 58,976 |
| End Cash Position | 69,856 | 112,915 | 151,867 | 199,810 | 386,200 |
| Net Cash Flow | $-316,344 | $-273,285 | $-234,333 | $-186,390 | $327,224 |
| Free Cash Flow | |||||
| Operating Cash Flow | -121,393 | -70,300 | -41,885 | -13,205 | -46,628 |
| Capital Expenditure | -6,555 | -5,173 | -3,454 | -1,246 | -1,155 |
| Free Cash Flow | -127,948 | -75,473 | -45,339 | -14,451 | -47,783 |